Business
Zealand Pharma convenes Extraordinary General Meeting on May 26, 2026
Company announcement – No. 12 / 2026 Zealand Pharma convenes Extraordinary General Meeting on May 26, 2026 Copenhagen, Denmark, May 1, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, hereby convenes an Extraordinary General Meeting. The Board of Directors of the Company hereby convenes an Extraordinary General Meeting (the "General Meeting") of the Company to be held on: Tuesday,
About this update from Zealand Pharma A/s
[{"type":"image","alt":"Zealand Pharma","displaySize":"","headline":null,"caption":"Zealand Pharma","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":121,"url":"https://media.zenfs.com/en/globenewswire.com/2567d307984f8639b4a7711f51c64eff"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/hruCjDK29WWlg5.YGk148A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE2OQ--/https://media.zenfs.com/en/globenewswire.com/2567d307984f8639b4a7711f51c64eff","width":300,"height":121}},"lazy":false},{"type":"text","content":"Company announcement – No. 12 / 2026","length":36,"tagName":"p"},{"type":"text","content":"Zealand Pharma convenes Extraordinary General Meeting on May 26, 2026 ","length":69,"tagName":"p"},{"type":"text","content":"Copenhagen, Denmark, May 1, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, hereby convenes an Extraordinary General Meeting.","length":253,"tagName":"p"},{"type":"text","content":"The Board of Directors of the Company hereby convenes an Extraordinary General Meeting (the "General Meeting") of the Company to be held on:","length":150,"tagName":"p"},{"type":"text","content":"Tuesday, May 26, 2026, at 1:00 pm (CEST)","length":40,"tagName":"p"},{"type":"text","content":"The General Meeting will be held as a physical meeting at Plesner Advokatpartnerselskab, Amerika Plads 37, 2100 Copenhagen Ø, Denmark.","length":134,"tagName":"p"},{"type":"text","content":"No live webcast or recording will be made in connection with the General Meeting.","length":81,"tagName":"p"},{"type":"text","content":"Further information, including the agenda and practical details regarding participation and voting, is set out in the accompanying materials.","length":141,"tagName":"p"},{"type":"text","content":"About Zealand Pharma ","length":20,"tagName":"p"},{"type":"text","content":"Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary data platform that leverages advanced data‑driven and AI/ML approaches, Zealand Pharma aims to lead a new era in obesity and metabolic health.","length":345,"tagName":"p"},{"type":"text","content":"To date, more than 10 Zealand Ph...